Nutra News made Easy
Recent studies suggest a promising role for probiotics in mental health, specifically through their impact on the gut-brain axis. Research shows that probiotics can modulate brain activity related to emotional regulation and cognitive processing, as revealed by task-based functional MRI studies. These findings extend to patients with major depressive disorder and irritable bowel syndrome (IBS),… Read More
A recent study has shown that Metabolaid, a natural blend of lemon verbena and hibiscus from Monteloeder, may significantly support weight loss efforts. Backed by 10 preclinical and clinical studies, Metabolaid has been linked to increased levels of GLP-1, a hormone crucial for regulating appetite and satiety. In a trial involving 61 overweight adults taking… Read More
The FDA has approved Cobenfy (xanomeline and trospium chloride) for treating schizophrenia in adults, marking a breakthrough as the first antipsychotic to target cholinergic receptors instead of dopamine receptors. Schizophrenia, a chronic mental illness affecting about 1% of Americans, causes psychotic symptoms and cognitive difficulties, and is a leading cause of disability globally. Cobenfy’s efficacy… Read More
A recent study highlights the promise of algae as a sustainable, nutritious protein source comparable to soy. In a randomized, controlled trial, 19 healthy Chinese males consumed noodle meals enriched with either nori or Chlorella vulgaris biomass/protein concentrate, alongside a soy protein control. The algae-enriched meals performed well in palatability, with nori and Chlorella outperforming… Read More
The biotics market for women’s health is rapidly evolving, with industry leaders highlighting abundant opportunities driven by a growing recognition of women’s unique health needs and a rising trend towards proactive self-care. Experts from Gnosis by Lesaffre, Lallemand Health Solutions, ADM, and AB-Biotics discuss the shift toward targeted solutions, particularly in the realm of vaginal… Read More